Simtra BioPharma Solutions has purchased a 65-acre property with more than 300,000 square feet of available space for ...

The European Commission has approved Sanofi’s Sarclisa in combination with bortezomib, lenalidomide, and dexamethasone (VRd) ...

AstraZeneca has announced a $50 billion investment in the United States by 2030, creating tens of thousands of new, highly ...

Tablet lubricants play a key role in pharmaceutical manufacturing, affecting everything from compression behavior to tablet ...

Operational strategies to optimize efficiency and cost effectiveness, and secure an unbroken chain of custody from ...

Matchpoint Therapeutics has entered into an exclusive option and license agreement with Novartis to develop and commercialize oral covalent inhibitors.

Jeff Sheehan, Managing Partner at Trinity Capital, Spark’s developer, commented, “Coriolis Pharma’s decision to establish ...

BGENE-DMD is designed to treat Duchenne muscular dystrophy (DMD) via a one-time administration in a single AAV.

Bristol Myers Squibb has appointed Cristian Massacesi, M.D., as Executive Vice President, Chief Medical Officer, and Head of Development.

Abzena, an end-to-end integrated CDMO and CRO, has appointed Geoffrey M. Glass as Chief Executive Officer (CEO), effective ...

Roquette, a provider of plant-based ingredients and pharmaceutical excipients, has launched POLYOX Extended Stability (ES) ...

Solvias' Center of Excellence for biologics and novel modalities in Research Triangle Park, North Carolina, is now cGMP ready ...